Weizmann Institute researchers discover immune memory cells capable of producing antibodies against cancer – a finding that opens new avenues for future cancer vaccines
After transforming the treatment of blood cancers, the CAR-T approach developed at the Weizmann Institute is now showing promise in a mouse model of Alzheimer’s disease
Weizmann Institute researchers have solved a 50-year-old mystery, uncovering the molecular mechanism that enables tissue regeneration after extensive damage. The findings may pave the way for treatments that help prevent cancer from returning